Work

North Central Cancer Treatment Group Phase II Study of 5-Fluorouracil and High-Dose Levamisole for Gastric and Gastroesophageal Cancer Using Survival as the Primary Endpoint of Efficacy

Year: 1999

Type: article

Study design: Clinical Trial

Source: American Journal of Clinical Oncology

DOI: 10.1097/00000421-199910000-00017

Authors: Patrick A. Burch, Michael D. Keppen, Georgene Schroeder, Joseph Rubin, James E. Krook, Robert J. Dalton, James B. Gerstner, Miroslav T. Jancewicz, Larry P. Ebbert

Institutions: Mayo Clinic, Saskatoon Cancer Centre

Language: English

Topic: Gastric Cancer Management and Outcomes

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: G358241105, G42877212, Community Clinical Oncology Program, North Central Cancer Treatment Group, G844520391, Mayo Clinic Comprehensive Cancer Center Support Grant

OpenAlex ID: W2033556358

FWCI: 0.319

Cites: 22

Cited by: 4

Related to: 10